These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 2467589)
1. Sufentanil, morphine, met-enkephalin, and kappa-agonist (U-50,488H) inhibit substance P release from primary sensory neurons: a model for presynaptic spinal opioid actions. Chang HM; Berde CB; Holz GG; Steward GF; Kream RM Anesthesiology; 1989 Apr; 70(4):672-7. PubMed ID: 2467589 [TBL] [Abstract][Full Text] [Related]
2. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse. Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883 [TBL] [Abstract][Full Text] [Related]
3. Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo. Sheldon RJ; Nunan L; Porreca F J Pharmacol Exp Ther; 1987 Oct; 243(1):234-40. PubMed ID: 2822899 [TBL] [Abstract][Full Text] [Related]
4. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat. Fox DA; Burks TF J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341 [TBL] [Abstract][Full Text] [Related]
5. Kappa and delta opioid receptor stimulation affects cardiac myocyte function and Ca2+ release from an intracellular pool in myocytes and neurons. Ventura C; Spurgeon H; Lakatta EG; Guarnieri C; Capogrossi MC Circ Res; 1992 Jan; 70(1):66-81. PubMed ID: 1309318 [TBL] [Abstract][Full Text] [Related]
6. Opioidergic inhibition of capsaicin-evoked release of glutamate from rat spinal dorsal horn slices. Ueda M; Sugimoto K; Oyama T; Kuraishi Y; Satoh M Neuropharmacology; 1995 Mar; 34(3):303-8. PubMed ID: 7630485 [TBL] [Abstract][Full Text] [Related]
7. Kappa-/mu-receptor interactions in the opioid control of the in vivo release of substance P-like material from the rat spinal cord. Collin E; Mauborgne A; Bourgoin S; Mantelet S; Ferhat L; Hamon M; Cesselin F Neuroscience; 1992 Nov; 51(2):347-55. PubMed ID: 1281527 [TBL] [Abstract][Full Text] [Related]
8. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action. Millan MJ; Członkowski A; Lipkowski A; Herz A J Pharmacol Exp Ther; 1989 Oct; 251(1):342-50. PubMed ID: 2571723 [TBL] [Abstract][Full Text] [Related]
9. Opioid control of the release of calcitonin gene-related peptide-like material from the rat spinal cord in vivo. Collin E; Frechilla D; Pohl M; Bourgoin S; Le Bars D; Hamon M; Cesselin F Brain Res; 1993 Apr; 609(1-2):211-22. PubMed ID: 8389648 [TBL] [Abstract][Full Text] [Related]
10. Mu and delta opioid receptors mediate opposite modulations by morphine of the spinal release of cholecystokinin-like material. Benoliel JJ; Collin E; Mauborgne A; Bourgoin S; Legrand JC; Hamon M; Cesselin F Brain Res; 1994 Aug; 653(1-2):81-91. PubMed ID: 7982079 [TBL] [Abstract][Full Text] [Related]
11. Cross-tolerance between mu- and kappa-opioid agonists in the guinea pig ileum myenteric plexus. Garaulet JV; Laorden ML; Milanés MV J Pharmacol Exp Ther; 1994 Jun; 269(3):993-9. PubMed ID: 8014886 [TBL] [Abstract][Full Text] [Related]
12. Morphine, but not sodium cromoglycate, modulates the release of substance P from capsaicin-sensitive neurones in the rat trachea in vitro. Ray NJ; Jones AJ; Keen P Br J Pharmacol; 1991 Apr; 102(4):797-800. PubMed ID: 1713104 [TBL] [Abstract][Full Text] [Related]
13. Morphine reduces the release of met-enkephalin-like material from the rat spinal cord in vivo by acting at delta opioid receptors. Collin E; Mauborgne A; Bourgoin S; Benoliel JJ; Hamon M; Cesselin F Neuropeptides; 1994 Jul; 27(1):75-83. PubMed ID: 7969822 [TBL] [Abstract][Full Text] [Related]
14. Kappa-opioid receptor stimulation abolishes mu- but not delta-mediated inhibitory control of spinal Met-enkephalin release. Collin E; Bourgoin S; Ferhat L; Hamon M; Cesselin F Neurosci Lett; 1992 Jan; 134(2):238-42. PubMed ID: 1317026 [TBL] [Abstract][Full Text] [Related]
15. Opioid modulation of capsaicin-evoked release of substance P from rat spinal cord in vivo. Aimone LD; Yaksh TL Peptides; 1989; 10(6):1127-31. PubMed ID: 2482963 [TBL] [Abstract][Full Text] [Related]
16. Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation. Shook JE; Lemcke PK; Gehrig CA; Hruby VJ; Burks TF J Pharmacol Exp Ther; 1989 Apr; 249(1):83-90. PubMed ID: 2540324 [TBL] [Abstract][Full Text] [Related]
17. Tonic pain perception in the mouse: differential modulation by three receptor-selective opioid agonists. Murray CW; Cowan A J Pharmacol Exp Ther; 1991 Apr; 257(1):335-41. PubMed ID: 1850470 [TBL] [Abstract][Full Text] [Related]
18. Modulation of cholinergic neurotransmission in guinea-pig airways by opioids. Belvisi MG; Stretton CD; Barnes PJ Br J Pharmacol; 1990 May; 100(1):131-7. PubMed ID: 1695531 [TBL] [Abstract][Full Text] [Related]
19. The effects of sham and full spinalization on the systemic potency of mu- and kappa-opioids on spinal nociceptive reflexes in rats. Herrero JF; Headley PM Br J Pharmacol; 1991 Sep; 104(1):166-70. PubMed ID: 1664760 [TBL] [Abstract][Full Text] [Related]
20. Inhibition by spinal mu- and delta-opioid agonists of afferent-evoked substance P release. Kondo I; Marvizon JC; Song B; Salgado F; Codeluppi S; Hua XY; Yaksh TL J Neurosci; 2005 Apr; 25(14):3651-60. PubMed ID: 15814796 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]